A New Paradigm for the Treatment of Secondary Hyperparathyroidism

The global rise in chronic kidney disease makes secondary hyperparathyroidism (SHPT) a growing medical concern. Conventional therapies for treating SHPT are limited and include calcium-based and calcium-free phosphate binders for reducing serum phosphorus and vitamin D or its analogues for simultane...

Descripción completa

Detalles Bibliográficos
Autores principales: de Francisco, Angel L. M., Carrera, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421151/
https://www.ncbi.nlm.nih.gov/pubmed/25983953
http://dx.doi.org/10.1093/ndtplus/sfm041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421151/
https://www.ncbi.nlm.nih.gov/pubmed/25983953
http://dx.doi.org/10.1093/ndtplus/sfm041

Ejemplares similares